AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Actinogen Medical Limited
Video analysis: ATGGF
All videosNo video analysis for this stock yet. Request one from our team.
News: ATGGF
Dow slips, Nasdaq edges lower as August ends in green
4:30pm: Wall Street caps winning month Wall Street closed lower on Monday, but the major indexes still wrapped up a winning August as investors look ahead...
Nvidia's $12.9bn Hugging Face swoop is really about filling the cloud capacity it has underwritten
The price Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) is reported to be paying is the first thing analysts have flagged, and on the face of it $12.9 billion for...
UBS says bond market relief from falling yields will not offset deeper structural pressures
UBS has said recent falls in bond yields and oil prices offer only temporary relief, with structural forces likely to keep long-term borrowing costs high,...
Riot Platforms $9.1B AI deal fuels speculation around Anthropic IPO
Riot Platforms Inc (NASDAQ:RIOT) shares rose about 4% on Tuesday after the bitcoin mining company announced a 20-year data center lease with a leading...
Traders see little chance of Hormuz shipping recovery by end of August
Prediction market traders have cut the odds of a meaningful recovery in shipping through the Strait of Hormuz by the end of this month, despite renewed talk...
Hikma jumps 10% as brokers point to profit beat and undemanding rating
Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares rose 10% to 1,721p after first-half results came in ahead of expectations on profits, with both Peel...
Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results
Actinogen Medical Ltd (ASX:ACW, OTC:ATGGF) has outlined the scientific rationale supporting its lead drug candidate Xanamem® (emestedastat) as a potential...
The Small Cap Watch: Healthcare, critical minerals and gold explorers advance projects
The S&P/ASX Small Ordinaries Index (ASX) closed at 3,482.30 on Wednesday, August 5, gaining 80.50 points or 2.37%. The index has risen 170.20 points, or...
